Uploaded September 2026 | Updated September 2026, 1 hour ago

---

Hear expert perspectives on how decisions at the lab bench today can affect clinical translation tomorrow. This 7-minute excerpt is part of a longer conversation about hPSC-derived cell therapy development, available to watch here:
stemcell.com/psc-therapy-panel

Panelists:

Dr. Nika Shakiba, Assistant Professor, School of Biomedical Engineering, University of British Columbia

Dr. Ross Jones, Postdoctoral Fellow, Stem Cell Bioengineering Lab, University of British Columbia

Dr. Richard Carpenedo, Lead Bioprocess Engineer, Immune Cell Manufacturing Hub, University of British Columbia

Dr. Andrew Gaffney, Vice President, iPSC Platform, STEMCELL Technologies

Lynn Csontos, Vice President, Regulatory Affairs, STEMCELL Technologies